Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nerve Growth Factor Receptor TrkA is a receptor tyrosine kinase that binds NGF with high affinity and mediates most of NGF's biological effects, including neuronal survival, differentiation, and pain perception. It is involved in various diseases, including congenital insensitivity to pain, intellectual disability, and certain cancers, making it a target for therapeutic intervention.
NGF binding induces receptor dimerization and autophosphorylation, activating downstream signaling pathways (Ras/MAPK, PI3K/Akt, PLCγ) that regulate neuronal survival, differentiation, and other functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nerve Growth Factor Receptor TrkA (TrkA).